Wealth Enhancement Advisory Services, LLC Crispr Therapeutics Ag Transaction History
Wealth Enhancement Advisory Services, LLC
- $40.3 Billion
- Q2 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 31,898 shares of CRSP stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,898
Previous 13,659
133.53%
Holding current value
$1.42 Million
Previous $930,000
85.16%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$351 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$347 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$141 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$141 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$124 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.48B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....